Exelixis Inc

13. Okt. 2026, 20:08 UTC

Exelixis Inc shares are modestly lower, retracing from an early gain, amid a broader market decline.

12. Okt. 2026, 21:02 UTC

Exelixis Inc shares declined in after-market trading, continuing lower since Monday's close and diverging from a recent trend of higher daily closes.

9. Okt. 2026, 20:06 UTC

RBC Capital raised its price target on Exelixis Inc to $51 while maintaining a Sector Perform rating, coinciding with the stock's positive performance.

8. Okt. 2026, 20:07 UTC

Exelixis Inc's shares advanced, supported by broader market strength, maintaining an upward trajectory despite an earlier pullback from a session high.

7. Okt. 2026, 19:45 UTC

Exelixis Inc shares are trading higher as Truist Securities raises the price target to $54.00 from $52.00 while maintaining a Hold rating.

6. Okt. 2026, 21:01 UTC

Exelixis Inc is trading modestly lower in after-market hours, positioned around the midpoint of its one-month trading range.

5. Okt. 2026, 21:10 UTC

Exelixis Inc. is advancing in after-market trading, closing at its highest point of the day after three consecutive sessions of gains.

2. Okt. 2026, 20:00 UTC

Exelixis Inc shares are advancing, reaching a peak cumulative return and remaining well above their 20-day moving average during Friday's market session.

1. Okt. 2026, 20:07 UTC

Exelixis Inc's shares fell modestly, reflecting routine performance amid broader market conditions, and are currently near the low end of their daily range.

30. Sept. 2026, 23:20 UTC

Exelixis Inc shares are higher in after-market trading, continuing a five-day gain, supported by strong Q2 GDP growth despite mixed inflation and consumer spending signals.

29. Sept. 2026, 20:31 UTC

Exelixis Inc saw a significant decline in after-market trading, continuing a downward trend since Tuesday's close following earlier gains.

28. Sept. 2026, 19:16 UTC

Exelixis Inc is trading modestly higher, currently 2.25% above its 20-day moving average, reflecting routine activity for this time of day.

25. Sept. 2026, 23:20 UTC

Exelixis Inc is lower in after-market trading, retracing from an early gain and reflecting a decline since Friday's close.

24. Sept. 2026, 20:01 UTC

Exelixis Inc is advancing, peaking in mid-afternoon while remaining above its 20-day moving average and near the upper end of its one-month range.

23. Sept. 2026, 20:07 UTC

Exelixis Inc shares fell significantly on Wednesday, having briefly spiked earlier in the session, reflecting a lack of momentum in either direction.

22. Sept. 2026, 20:06 UTC

Exelixis Inc is gaining today, building on Monday's momentum, with the stock remaining above its 20-day moving average and near its one-month range's upper end.

21. Sept. 2026, 23:25 UTC

Exelixis Inc is trading modestly lower in after-market hours, continuing a decline seen over the past three sessions after reaching a session high.

18. Sept. 2026, 20:06 UTC

Exelixis Inc's shares fell sharply after reaching a notable peak earlier in the session, while remaining above the 20-day moving average.

16. Sept. 2026, 20:07 UTC

Exelixis Inc shares fell sharply, retracing from an early peak in cumulative return amid unusually high market volume on Wednesday.

15. Sept. 2026, 20:07 UTC

Exelixis Inc. shares are higher as the company expands CABOMETYX in renal cell carcinoma and neuroendocrine tumors, reflecting investor confidence amid broader market concerns.

14. Sept. 2026, 20:07 UTC

Exelixis shares are rising after BMO indicated the FDA's PDUFA date extension for Zanzalintinib is procedural, maintaining a $55 price target.

11. Sept. 2026, 20:01 UTC

Exelixis shares are lower as the FDA extends the review period for zanzalintinib by three months, now set for March 3, 2027.

10. Sept. 2026, 20:07 UTC

Exelixis Inc shares are lower amid market reaction to the European Central Bank's interest rate hike. The stock briefly recovered earlier in the session.

9. Sept. 2026, 20:07 UTC

Exelixis announced a $2 million milestone payment to Adagene for preclinical progress on the XB404 program, boosting shares in Wednesday's session.

8. Sept. 2026, 19:51 UTC

Exelixis Inc shares are lower today, influenced by a decline in the Biotechnology sub-sector, breaking a trend of higher daily closes since Friday.

3. Sept. 2026, 20:07 UTC

Exelixis Inc is advancing during Thursday's session, maintaining upward momentum since Wednesday. No specific news was identified to explain the price movement.

2. Sept. 2026, 23:56 UTC

Exelixis Inc shares are higher in after-market trading, though no specific news was identified. The broader market reacted to weaker ADP payroll data.

1. Sept. 2026, 23:06 UTC

Exelixis Inc. shares are lower in after-market hours, with no specific news identified for the decline amid broader market concerns.

31. Aug. 2026, 22:16 UTC

Exelixis shares are higher in after-market hours, rebounding from a slight dip earlier. This follows broader market reactions to Federal Reserve comments on inflation.

28. Aug. 2026, 23:01 UTC

Exelixis Inc shares are lower in after-market hours, continuing a trend of declines amid rising interest rate hike expectations affecting the biotechnology sector.